Works by Subklewe, Marion

Results: 86
    1
    2

    Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia.

    Published in:
    Journal of Clinical Medicine, 2019, v. 8, n. 5, p. 579, doi. 10.3390/jcm8050579
    By:
    • Van Acker, Heleen H.;
    • Versteven, Maarten;
    • Lichtenegger, Felix S.;
    • Roex, Gils;
    • Campillo-Davo, Diana;
    • Lion, Eva;
    • Subklewe, Marion;
    • Van Tendeloo, Viggo F.;
    • Berneman, Zwi N.;
    • Anguille, Sébastien
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9

    Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 12, p. 1847, doi. 10.1002/ajh.27087
    By:
    • Ravandi, Farhad;
    • Cloos, Jacqueline;
    • Buccisano, Francesco;
    • Dillon, Richard;
    • Döhner, Konstanze;
    • Freeman, Sylvie D.;
    • Hourigan, Christopher S.;
    • Ossenkoppele, Gerrit J.;
    • Roboz, Gail J.;
    • Subklewe, Marion;
    • Thiede, Christian;
    • Arnhardt, Isabell;
    • Valk, Peter J. M.;
    • Venditti, Adriano;
    • Wei, Andrew H.;
    • Walter, Roland B.;
    • Heuser, Michael
    Publication type:
    Article
    10

    The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
    By:
    • Rejeski, Kai;
    • Wang, Yucai;
    • Albanyan, Omar;
    • Munoz, Javier;
    • Sesques, Pierre;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Ries, Isabelle;
    • Bücklein, Veit L.;
    • Mohty, Razan;
    • Dreyling, Martin;
    • Baluch, Aliyah;
    • Shah, Bijal;
    • Locke, Frederick L.;
    • Hess, Georg;
    • Barba, Pere;
    • Bachy, Emmanuel;
    • Lin, Yi;
    • Subklewe, Marion;
    • Jain, Michael D.
    Publication type:
    Article
    11
    12
    13
    14
    15

    Predicting work ability impairment in post COVID-19 patients: a machine learning model based on clinical parameters.

    Published in:
    Infection, 2025, v. 53, n. 3, p. 1189, doi. 10.1007/s15010-024-02459-8
    By:
    • Jebrini, Tarek;
    • Ruzicka, Michael;
    • Völk, Felix;
    • Fonseca, Gerardo Jesus Ibarra;
    • Pernpruner, Anna;
    • Benesch, Christopher;
    • Valdinoci, Elisabeth;
    • von Baum, Max;
    • Weigl, Martin;
    • Subklewe, Marion;
    • von Bergwelt-Baildon, Michael;
    • Roider, Julia;
    • Mayerle, Julia;
    • Heindl, Bernhard;
    • Adorjan, Kristina;
    • Stubbe, Hans Christian
    Publication type:
    Article
    16
    17

    Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma.

    Published in:
    HemaSphere, 2025, v. 9, n. 1, p. 1, doi. 10.1002/hem3.70062
    By:
    • Stock, Sophia;
    • Bücklein, Veit L.;
    • Blumenberg, Viktoria;
    • Magno, Giulia;
    • Emhardt, Alica‐Joana;
    • Holzem, Alessandra M. E.;
    • Cordas dos Santos, David M.;
    • Schmidt, Christian;
    • Grießhammer, Stefanie;
    • Frölich, Lisa;
    • Kobold, Sebastian;
    • von Bergwelt‐Baildon, Michael;
    • Rejeski, Kai;
    • Subklewe, Marion
    Publication type:
    Article
    18

    P1151: BENDAMUSTINE-CONTAINING REGIMENS CAN BE SAFELY USED AS BRIDGING IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY.

    Published in:
    2023
    By:
    • Garcia-Calvo, Gloria Ines Iacoboni;
    • Navarro, Victor;
    • Lopez, Ana Africa Martin;
    • Bastos Oreiro, Mariana;
    • Rejeski, Kai;
    • Aleksandra Jalowiec, Katarzyna;
    • Amat, Paula;
    • Ortega, Juan Luis Reguera;
    • Blumenberg, Viktoria;
    • Gallur, Laura;
    • Herrero-García, María;
    • Roddie, Claire;
    • Bailen, Rebeca;
    • Benzaquen, Ana;
    • Segura, Cecilia Carmen Carpio;
    • López Corral, Lucía;
    • Hernani, Rafael;
    • Kwon, MI;
    • Martín-Martín, Lourdes;
    • Subklewe, Marion
    Publication type:
    Abstract
    19
    20
    21

    Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR‐T for Relapsed/Refractory B‐NHL.

    Published in:
    HemaSphere, 2023, v. 7, n. 4, p. e858, doi. 10.1097/HS9.0000000000000858
    By:
    • Rejeski, Kai;
    • Blumenberg, Viktoria;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Kharboutli, Soraya;
    • Hernani, Rafael;
    • Petrera, Agnese;
    • Müller, Niklas;
    • Hildebrand, Friederike;
    • Frölich, Lisa;
    • Karschnia, Philipp;
    • Schmidt, Christian;
    • Cordas dos Santos, David M.;
    • Piñana, José Luis;
    • Müller, Fabian;
    • Martin, Ana Africa;
    • Dreyling, Martin;
    • von Bergwelt‐Baildon, Michael;
    • Barba, Pere;
    • Subklewe, Marion
    Publication type:
    Article
    22
    23

    Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 9, p. 1281, doi. 10.1080/10428194.2024.2346755
    By:
    • Ravandi, Farhad;
    • Subklewe, Marion;
    • Walter, Roland B.;
    • Vachhani, Pankit;
    • Ossenkoppele, Gert;
    • Buecklein, Veit;
    • Döhner, Hartmut;
    • Jongen-Lavrencic, Mojca;
    • Baldus, Claudia D.;
    • Fransecky, Lars;
    • Pardee, Timothy S.;
    • Kantarjian, Hagop;
    • Yen, Priscilla K.;
    • Mukundan, Lata;
    • Panwar, Bharat;
    • Yago, Marc R.;
    • Agarwal, Suresh;
    • Khaldoyanidi, Sophia K.;
    • Stein, Anthony
    Publication type:
    Article
    24
    25

    Immunotherapy in Tumors.

    Published in:
    Deutsches Ärzteblatt International, 2015, v. 112, n. 48, p. 809, doi. 10.3238/arztebl.2015.0809
    By:
    • Kobold, Sebastian;
    • Duewell, Peter;
    • Schnurr, Max;
    • Subklewe, Marion;
    • Rothenfusser, Simon;
    • Endres, Stefan
    Publication type:
    Article
    26
    27

    Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
    By:
    • Voltin, Conrad-Amadeus;
    • Paccagnella, Andrea;
    • Winkelmann, Michael;
    • Heger, Jan-Michel;
    • Casadei, Beatrice;
    • Beckmann, Laura;
    • Herrmann, Ken;
    • Dekorsy, Franziska J.;
    • Kutsch, Nadine;
    • Borchmann, Peter;
    • Fanti, Stefano;
    • Kunz, Wolfgang G.;
    • Subklewe, Marion;
    • Kobe, Carsten;
    • Zinzani, Pier Luigi;
    • Stelljes, Matthias;
    • Roth, Katrin S.;
    • Drzezga, Alexander;
    • Noppeney, Richard;
    • Rahbar, Kambiz
    Publication type:
    Article
    28

    Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 5, p. 1406, doi. 10.1007/s00259-022-06075-2
    By:
    • Winkelmann, Michael;
    • Blumenberg, Viktoria;
    • Rejeski, Kai;
    • Bücklein, Veit L.;
    • Ruzicka, Michael;
    • Unterrainer, Marcus;
    • Schmidt, Christian;
    • Dekorsy, Franziska J.;
    • Bartenstein, Peter;
    • Ricke, Jens;
    • von Bergwelt-Baildon, Michael;
    • Subklewe, Marion;
    • Kunz, Wolfgang G.
    Publication type:
    Article
    29
    30

    Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphoma.

    Published in:
    EJNMMI Research, 2025, v. 15, n. 1, p. 1, doi. 10.1186/s13550-025-01201-1
    By:
    • Beck, Michael;
    • Blumenberg, Viktoria;
    • Bücklein, Veit L.;
    • Bundschuh, Ralph A.;
    • Harrer, Dennis C.;
    • Hirschbühl, Klaus;
    • Jung, Johannes;
    • Kunz, Wolfgang G.;
    • Menhart, Karin;
    • Winkelmann, Michael;
    • Yakushev, Igor;
    • Illert, Anna Lena;
    • Eckstein, Markus;
    • Völkl, Simon;
    • Claus, Rainer;
    • Hansmann, Leo;
    • Hecker, Judith S.;
    • Kuwert, Torsten;
    • Mackensen, Andreas;
    • Subklewe, Marion
    Publication type:
    Article
    31

    In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer.

    Published in:
    OncoImmunology, 2023, v. 12, n. 1, p. 1, doi. 10.1080/2162402X.2022.2163781
    By:
    • Xu, Tao;
    • Karschnia, Philipp;
    • Cadilha, Bruno Loureiro;
    • Dede, Sertac;
    • Lorenz, Michael;
    • Seewaldt, Niklas;
    • Nikolaishvili, Elene;
    • Müller, Katharina;
    • Blobner, Jens;
    • Teske, Nico;
    • Herold, Julika J.;
    • Rejeski, Kai;
    • Langer, Sigrid;
    • Obeck, Hannah;
    • Lorenzini, Theo;
    • Mulazzani, Matthias;
    • Zhang, Wenlong;
    • Ishikawa-Ankerhold, Hellen;
    • Buchholz, Veit R.;
    • Subklewe, Marion
    Publication type:
    Article
    32

    Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.

    Published in:
    OncoImmunology, 2018, v. 7, n. 9, p. 1, doi. 10.1080/2162402X.2018.1472195
    By:
    • Braciak, Todd A.;
    • Roskopf, Claudia C.;
    • Spiekermann, Karsten;
    • Oduncu, Fuat S.;
    • Krupka, Christina;
    • Subklewe, Marion;
    • Wildenhain, Sarah;
    • Fenn, Nadja C.;
    • Schiller, Christian B.;
    • Hopfner, Karl-Peter;
    • Schubert, Ingo A.;
    • Fey, Georg H.;
    • Jacob, Uwe;
    • Honegger, Annemarie;
    • Aigner, Michael;
    • Krause, Stefan;
    • Mackensen, Andreas
    Publication type:
    Article
    33
    34

    Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infection.

    Published in:
    Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32772-5
    By:
    • Khatamzas, Elham;
    • Antwerpen, Markus H.;
    • Rehn, Alexandra;
    • Graf, Alexander;
    • Hellmuth, Johannes Christian;
    • Hollaus, Alexandra;
    • Mohr, Anne-Wiebe;
    • Gaitzsch, Erik;
    • Weiglein, Tobias;
    • Georgi, Enrico;
    • Scherer, Clemens;
    • Stecher, Stephanie-Susanne;
    • Gruetzner, Stefanie;
    • Blum, Helmut;
    • Krebs, Stefan;
    • Reischer, Anna;
    • Leutbecher, Alexandra;
    • Subklewe, Marion;
    • Dick, Andrea;
    • Zange, Sabine
    Publication type:
    Article
    35

    Advances in cancer immunotherapy 2019 – latest trends.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1266-0
    By:
    • Kruger, Stephan;
    • Ilmer, Matthias;
    • Kobold, Sebastian;
    • Cadilha, Bruno L.;
    • Endres, Stefan;
    • Ormanns, Steffen;
    • Schuebbe, Gesa;
    • Renz, Bernhard W.;
    • D'Haese, Jan G.;
    • Schloesser, Hans;
    • Heinemann, Volker;
    • Subklewe, Marion;
    • Boeck, Stefan;
    • Werner, Jens;
    • von Bergwelt-Baildon, Michael
    Publication type:
    Article
    36

    Cellular therapy in lymphoma.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 6, p. 1, doi. 10.1002/hon.3200
    By:
    • Sureda, Anna;
    • Lugtenburg, Pieternella J.;
    • Kersten, Marie José;
    • Subklewe, Marion;
    • Spanjaart, Anne;
    • Shah, Nirali N;
    • Kerbauy, Lucila N;
    • Roddie, Clarie;
    • Pennings, Elise R. A.;
    • Mahuad, Carolina;
    • Poon, Michelle;
    • Hendricks, Candice L;
    • Kamdar, Manali;
    • Jacobson, Caron
    Publication type:
    Article
    37
    38
    39

    Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy.

    Published in:
    Annals of Hematology, 2024, v. 103, n. 1, p. 259, doi. 10.1007/s00277-023-05507-9
    By:
    • Winkelmann, Michael;
    • Blumenberg, Viktoria;
    • Rejeski, Kai;
    • Quell, Christina;
    • Bücklein, Veit L.;
    • Ingenerf, Maria;
    • Unterrainer, Marcus;
    • Schmidt, Christian;
    • Dekorsy, Franziska J.;
    • Bartenstein, Peter;
    • Ricke, Jens;
    • von Bergwelt-Baildon, Michael;
    • Subklewe, Marion;
    • Kunz, Wolfgang G.
    Publication type:
    Article
    40

    Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 6, p. 1, doi. 10.1007/s00262-024-03688-4
    By:
    • Stock, Sophia;
    • Fertig, Luisa;
    • Gottschlich, Adrian;
    • Dörr, Janina;
    • Märkl, Florian;
    • Majed, Lina;
    • Menkhoff, Vivien D.;
    • Grünmeier, Ruth;
    • Rejeski, Kai;
    • Cordas dos Santos, David M.;
    • Theurich, Sebastian;
    • von Bergwelt-Baildon, Michael;
    • Endres, Stefan;
    • Subklewe, Marion;
    • Kobold, Sebastian
    Publication type:
    Article
    41

    Correction to: CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.

    Published in:
    2023
    By:
    • Marcinek, Anetta;
    • Brauchle, Bettina;
    • Rohrbacher, Lisa;
    • Hänel, Gerulf;
    • Philipp, Nora;
    • Märkl, Florian;
    • Strzalkowski, Thaddäus;
    • Lacher, Sonja M.;
    • Udiljak, Dragica;
    • Spiekermann, Karsten;
    • Theurich, Sebastian;
    • Kobold, Sebastian;
    • Kischel, Roman;
    • James, John R.;
    • Bücklein, Veit L.;
    • Subklewe, Marion
    Publication type:
    Correction Notice
    42

    CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 7, p. 2499, doi. 10.1007/s00262-023-03439-x
    By:
    • Marcinek, Anetta;
    • Brauchle, Bettina;
    • Rohrbacher, Lisa;
    • Hänel, Gerulf;
    • Philipp, Nora;
    • Märkl, Florian;
    • Strzalkowski, Thaddäus;
    • Lacher, Sonja M.;
    • Udiljak, Dragica;
    • Spiekermann, Karsten;
    • Theurich, Sebastian;
    • Kobold, Sebastian;
    • Kischel, Roman;
    • James, John R.;
    • Bücklein, Veit L.;
    • Subklewe, Marion
    Publication type:
    Article
    43
    44

    A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 7, p. 1353, doi. 10.1007/s00262-020-02552-5
    By:
    • Orth, Martin F.;
    • Buecklein, Veit Leonhard;
    • Kampmann, Eric;
    • Subklewe, Marion;
    • Noessner, Elfriede;
    • Cidre-Aranaz, Florencia;
    • Romero-Pérez, Laura;
    • Wehweck, Fabienne Sophie;
    • Lindner, Lars;
    • Issels, Rolf;
    • Kirchner, Thomas;
    • Altendorf-Hofmann, Annelore;
    • Grünewald, Thomas G. P.;
    • Knösel, Thomas
    Publication type:
    Article
    45

    RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML.

    Published in:
    Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1505, doi. 10.1007/s00262-015-1755-8
    By:
    • Lichtenegger, Felix;
    • Kondla, Isabell;
    • Krempasky, Michael;
    • Weber, Anna;
    • Herold, Tobias;
    • Krupka, Christina;
    • Spiekermann, Karsten;
    • Schneider, Stephanie;
    • Büchner, Thomas;
    • Berdel, Wolfgang;
    • Wörmann, Bernhard;
    • Hiddemann, Wolfgang;
    • Subklewe, Marion
    Publication type:
    Article
    46
    47
    48

    Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study.

    Published in:
    Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01379-0
    By:
    • Shah, Bijal D.;
    • Ghobadi, Armin;
    • Oluwole, Olalekan O.;
    • Logan, Aaron C.;
    • Boissel, Nicolas;
    • Cassaday, Ryan D.;
    • Leguay, Thibaut;
    • Bishop, Michael R.;
    • Topp, Max S.;
    • Tzachanis, Dimitrios;
    • O'Dwyer, Kristen M.;
    • Arellano, Martha L.;
    • Lin, Yi;
    • Baer, Maria R.;
    • Schiller, Gary J.;
    • Park, Jae H.;
    • Subklewe, Marion;
    • Abedi, Mehrdad;
    • Minnema, Monique C.;
    • Wierda, William G.
    Publication type:
    Article
    49

    SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells.

    Published in:
    Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01163-6
    By:
    • Tahk, Siret;
    • Vick, Binje;
    • Hiller, Björn;
    • Schmitt, Saskia;
    • Marcinek, Anetta;
    • Perini, Enrico D.;
    • Leutbecher, Alexandra;
    • Augsberger, Christian;
    • Reischer, Anna;
    • Tast, Benjamin;
    • Humpe, Andreas;
    • Jeremias, Irmela;
    • Subklewe, Marion;
    • Fenn, Nadja C.;
    • Hopfner, Karl-Peter
    Publication type:
    Article
    50

    First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 3, p. 1, doi. 10.1111/cts.13742
    By:
    • Narayan, Rupa;
    • Piérola, Ana Alfonso;
    • Donnellan, William B.;
    • Yordi, Antonieta Molero;
    • Abdul‐Hay, Maher;
    • Platzbecker, Uwe;
    • Subklewe, Marion;
    • Kadia, Tapan Mahendra;
    • Alonso‐Domínguez, Juan Manuel;
    • McCloskey, James;
    • Bradford, Kathryn;
    • Curtis, Martin;
    • Daskalakis, Nikki;
    • Guttke, Christina;
    • Safer, Karim;
    • Hiebert, Brett;
    • Murphy, Joseph;
    • Li, Xiang;
    • Duchin, Ken;
    • Esteban, Daniel
    Publication type:
    Article